EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Successful Management of Refractory Otitis Media Using Allergen‐Specific Immunotherapy in a Dog

Jihyun Kim, Ji-Hye Lee, Yeji Kim, Yunji Song, Ha-Jung Kim iD

Veterinary Medicine and Science · 2025

DOI: 10.1002/vms3.70253 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Veterinary Medicine and Science, 2025. Verfasst von Jihyun Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chonnam National University, Gwangju, South Korea. Hauptthemen laut MEDLINE: Dog Diseases, Otitis Media, Desensitization, Immunologic. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Ministry of Education, Kementerian Pendidikan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allergen‐specific immunotherapy (ASIT) is a highly effective treatment for atopic dermatitis. In humans, it has been reported to be significantly more effective than medication alone for the treatment of otitis media. ASIT can also be used in dogs, but it is not typically the first‐line treatment for otitis externa and media.

Objectives

This case report describes the successful management of refractory otitis media in a dog with frequent abscess recurrence following total ear canal ablation (TECA) using ASIT.

Methods

A 9‐year‐old spayed female American Cocker Spaniel presented with a head tilt and a recurrent abscess adjacent to the left TECA site. A dermatological examination revealed secondary pyoderma. In open‐mouth view radiography and CT, fluid in the tympanic bullae and lysis of the tympanic bullae wall were observed. The TECA was repeated twice and anti‐inflammatory medication was administered, but the lesions reappeared. As a fundamental treatment, ASIT was included in the therapy.

Results

After ASIT, the symptoms did not reoccur, even though the use of prednisolone was gradually reduced and discontinued over a period of two months. Currently, only ASIT has demonstrated progress in managing the patient's condition, even a year after discontinuing other medications. The patient's symptoms have not recurred and are well managed.

Conclusions

A case of refractory otitis media, induced by atopic dermatitis, was effectively managed with ASIT over a prolonged period in a dog.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesOtitis MediaDesensitization, ImmunologicDogsAnimalsFemaleTreatment OutcomeAllergens

Stichwörter der Autor:innen

allergen‐specific immunotherapyatopic dermatitisdogotitis mediatotal ear canal ablation

Substanzen

Allergens

Autor:innen und Institutionen

  • Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chonnam National University, Gwangju, South Korea.
  • BK 21 Project Team, College of Veterinary Medicine, Chonnam National University, Gwangju, South Korea.

ORCID-Profile: Ha-Jung Kim

Förderung

  • Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education
  • Ministry of Education
  • Kementerian Pendidikan

Zitieren

APA

Kim, J., Lee, J. H., Kim, Y., Song, Y., & Kim, H. J. (2025). Successful Management of Refractory Otitis Media Using Allergen‐Specific Immunotherapy in a Dog. Veterinary Medicine and Science. https://doi.org/10.1002/vms3.70253

Vancouver

Kim J, Lee JH, Kim Y, Song Y, Kim HJ. Successful Management of Refractory Otitis Media Using Allergen‐Specific Immunotherapy in a Dog. Veterinary Medicine and Science. 2025. doi:10.1002/vms3.70253

BibTeX
@article{Kim2025,
  author = {Kim, Jihyun and Lee, Ji-Hye and Kim, Yeji and Song, Yunji and Kim, Ha-Jung},
  title = {Successful Management of Refractory Otitis Media Using Allergen‐Specific Immunotherapy in a Dog},
  journal = {Veterinary Medicine and Science},
  year = {2025},
  doi = {10.1002/vms3.70253}
}
Kostenlos starten →